news
Psychedelics shift immune markers for faster depression relief
New research from The University of Texas MD Anderson Cancer Center found psychedelics like psilocybin and ketamine can change immune system markers linked to rapid depression relief, especially for cancer patients. They're looking into how brain and immune cells talk to each other to predict who responds best.
New research from The University of Texas MD Anderson Cancer Center found psychedelics like psilocybin and ketamine can change immune system markers linked to rapid depression relief, especially for cancer patients. They're looking into how brain and immune cells talk to each other to predict who responds best.
The architecture take
So, psychedelics aren't just messing with your head in a direct way; they're also doing something with your immune system. This study points to specific immune markers that shift when someone gets fast relief from depression with psilocybin or ketamine. I'm always thinking about the long game here, and if we can predict who's going to respond to these treatments — maybe by checking their inflammatory markers or specific cytokine levels — then that's huge for patient selection. No more throwing darts. It means fewer side effects for those who won't benefit and faster relief for those who will. The whole point is to reduce the load on an already stressed system, especially for people dealing with cancer. The nervous system doesn't operate in a vacuum, and this research just reinforces that you can't separate brain state from body state.